Equitable Access to High-Cost Pharmaceuticals (Paperback)

Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines.

General

Imprint:	Academic Press Inc
Country of origin:	United States
Release date:	February 2018
First published:	2018
Editors:	Zaheer-Ud-Din Babar
Dimensions:	229 x 152 x 18mm (L x W x T)
Format:	Paperback
Pages:	238
ISBN-13:	978-0-12-811945-7
Categories:	Books > Business & Economics > Economics > General Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries Books > Medicine > General issues > Public health & preventive medicine > General Books > Medicine > General issues > Health systems & services > General
LSN:	0-12-811945-4
Barcode:	9780128119457

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!